Corticobasal Syndrome Clinical Trials

9 recruitingLast updated: June 18, 2026

There are 9 actively recruiting corticobasal syndrome clinical trials across 4 countries. Studies span Not Applicable, Phase 2. Top locations include Toronto, Ontario, Canada, Bergen, Vestland, Norway, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Corticobasal Syndrome Trials at a Glance

9 actively recruiting trials for corticobasal syndrome are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Toronto, Bergen, and Boston. Lead sponsors running corticobasal syndrome studies include University Health Network, Toronto, Jennifer Whitwell, and Haukeland University Hospital.

Browse corticobasal syndrome trials by phase

Treatments under study

About Corticobasal Syndrome Clinical Trials

Looking for clinical trials for Corticobasal Syndrome? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Corticobasal Syndrome trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Corticobasal Syndrome clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

UPenn Observational Research Repository on Neurodegenerative Disease

Corticobasal Syndrome(CBS)Progressive Supranuclear Palsy (PSP)Primary Progressive Aphasia(PPA)+6 more
University of Pennsylvania1,000 enrolled1 locationNCT04715399
Recruiting
Not Applicable

Scrambler Therapy for Corticobasal Syndrome-Associated Pain

Corticobasal SyndromeCorticobasal DegenerationPain, Neuropathic
Johns Hopkins University25 enrolled1 locationNCT05653778
Recruiting

The CurePSP Genetics Program

Multiple System Atrophy, Parkinsonian TypeMultiple System Atrophy, Cerebellar TypeMultiple System Atrophy+15 more
Massachusetts General Hospital1,000 enrolled1 locationNCT06647641
Recruiting

Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling

DementiaAlzheimer DiseaseParkinson Disease+7 more
University Health Network, Toronto500 enrolled4 locationsNCT06529744
Recruiting
Not Applicable

STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners

Caregiver BurdenCorticobasal SyndromePrimary Progressive Aphasia(PPA)+1 more
Oregon Health and Science University640 enrolled1 locationNCT06613204
Recruiting

Imaging Studies in Corticobasal Syndrome

Corticobasal SyndromeCorticobasal Syndrome(CBS)Corticobasal Degeneration+2 more
Jennifer Whitwell80 enrolled1 locationNCT07000851
Recruiting

Diagnosing Frontotemporal Lobar Degeneration

Corticobasal SyndromeProgressive Supranuclear PalsySemantic Dementia+3 more
University Health Network, Toronto100 enrolled1 locationNCT02964637
Recruiting
Phase 2

The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism

Multiple System AtrophyCorticobasal SyndromeProgressive Supranuclear Palsy
Haukeland University Hospital330 enrolled3 locationsNCT06162013
Recruiting

Monash-Alfred Protocol for Assessment of Atypical Parkinsonian Syndromes (MAP-APS)

Multiple Systems AtrophyCorticobasal Syndrome
Alfred Health, Neurosciences department60 enrolled1 locationACTRN12622000923763